Get started
RocketTickers

Rhythm Pharmaceuticals Announces Positive Results from Phase 2 S

Long
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)  
RocketTickers  
NASDAQ:RYTM   Rhythm Pharmaceuticals, Inc.
Beyond Technical Analysis
4
0
beyondta
RYTM: Rhythm Pharmaceuticals, Inc.
2020-06-24 08:00:10
Rhythm Pharmaceuticals Announces Positive Results from Phase 2 Study of Once-weekly Formulation of Setmelanotide in Healthy Obese Volunteers
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.